DORZOLAMIDE HCL AND TIMOLOL MALEATE- dorzolamide hydrochloride and timolol maleate solution United States - English - NLM (National Library of Medicine)

dorzolamide hcl and timolol maleate- dorzolamide hydrochloride and timolol maleate solution

a-s medication solutions - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1), timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - dorzolamide hydrochloride-timolol maleate ophthalmic solution, usp is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target iop determined after multiple measurements over time). the iop-lowering of dorzolamide hydrochloride-timolol maleate ophthalmic solution, usp administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day [see clinical studies ( 14 )]. dorzolamide hydrochloride-timolol maleate ophthalmic solution is contraindicated in patients with bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease [see warnings and precautions ( 5.1 )]. dorzolamide hydrochloride-timolol maleate ophthalmic solution is contraindicated in patients with sinus bradycardia, second or third degree atrioventricular

DORZOLAMIDE/TIMOLOL SANDOZ 20/5 dorzolamide (as hydrochloride) 20 mg/mL and timolol (as maleate) 5 mg/mL eye drops solution bott Australia - English - Department of Health (Therapeutic Goods Administration)

dorzolamide/timolol sandoz 20/5 dorzolamide (as hydrochloride) 20 mg/ml and timolol (as maleate) 5 mg/ml eye drops solution bott

sandoz pty ltd - dorzolamide hydrochloride,timolol maleate -

DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION Canada - English - Health Canada

dorzolamide hydrochloride ophthalmic solution

bausch & lomb inc - dorzolamide (dorzolamide hydrochloride) - solution - 20mg - dorzolamide (dorzolamide hydrochloride) 20mg - carbonic anhydrase inhibitors

DORZOLAMIDE APOTEX dorzolamide (as hydrochloride) 20 mg/mL eye drops bottle Australia - English - Department of Health (Therapeutic Goods Administration)

dorzolamide apotex dorzolamide (as hydrochloride) 20 mg/ml eye drops bottle

arrotex pharmaceuticals pty ltd - dorzolamide hydrochloride, quantity: 22.3 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; water for injections; sodium hydroxide; hyetellose; sodium citrate dihydrate; mannitol - dorzolamide eye drops are indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

DORZOLAMIDE HCL AND TIMOLOL MALEATE hydrochloride solution United States - English - NLM (National Library of Medicine)

dorzolamide hcl and timolol maleate hydrochloride solution

actavis pharma, inc. - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1) - dorzolamide 20 mg in 1 ml

COSOPT PF- dorzolamide hydrochloride and timolol maleate solution/ drops United States - English - NLM (National Library of Medicine)

cosopt pf- dorzolamide hydrochloride and timolol maleate solution/ drops

akorn - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1), timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - dorzolamide 20 mg in 1 ml - cosopt® pf is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target iop determined after multiple measurements over time). the iop-lowering of cosopt® administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day [see clinical studies (14.1)]. cosopt pf is contraindicated in patients with bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease [see warnings and precautions (5.1)]. cosopt pf is contraindicated in patients with sinus bradycardia, second or third degree atrioventricular block, overt cardiac failure, and cardiogenic shock [see warnings and precautions (5.2)]. cosopt pf is contraindicated in patients who are hypersensitive to any component of this product [see warnings and precautions (5.3

Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dorzolamide 20mg/ml / timolol 5mg/ml eye drops

accord-uk ltd - dorzolamide hydrochloride; timolol maleate - eye drops - 20mg/1ml ; 5mg/1ml

DORZOLAMIDE Ireland - English - HPRA (Health Products Regulatory Authority)

dorzolamide

actavis group ptc ehf - dorzolamide hydrochloride - eye drops solution - 20 mg/ml - dorzolamide

Dorzolamide + Timolol PharmaSwiss 20 mg/ml + 5 mg/ml, eye drops solution Ireland - English - HPRA (Health Products Regulatory Authority)

dorzolamide + timolol pharmaswiss 20 mg/ml + 5 mg/ml, eye drops solution

pharmaswiss ceska republika s.r.o. - dorzolamide hydrochloride; timolol maleate - eye drops, solution - 20mg/ml+5 milligram(s)/millilitre - beta blocking agents1); timolol, combinations

Dorzolamide 20mg/ml eye drops, solution Ireland - English - HPRA (Health Products Regulatory Authority)

dorzolamide 20mg/ml eye drops, solution

accord healthcare ireland ltd. - dorzolamide hydrochloride - eye drops, solution - 20 milligram(s)/millilitre - carbonic anhydrase inhibitors; dorzolamide